Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. DBV Technologies
  6. Summary
    DBV   FR0010417345

DBV TECHNOLOGIES

(DBV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
9.318(c) 9.294(c) 9.99(c) 9.896(c) 10.245(c) Last
437 850 233 741 510 690 310 780 337 974 Volume
+1.04% -0.26% +7.49% -0.94% +3.53% Change
More quotes
Financials
Sales 2021 10,9 M 13,2 M 13,2 M
Net income 2021 -108 M -130 M -130 M
Net cash position 2021 73,7 M 89,1 M 89,1 M
P/E ratio 2021 -5,52x
Yield 2021 -
Sales 2022 32,1 M 38,8 M 38,8 M
Net income 2022 -114 M -138 M -138 M
Net cash position 2022 12,2 M 14,8 M 14,8 M
P/E ratio 2022 -5,94x
Yield 2022 -
Capitalization 562 M 680 M 681 M
EV / Sales 2021 44,8x
EV / Sales 2022 17,2x
Nbr of Employees 104
Free-Float 91,2%
More Financials
Company
DBV Technologies S.A. specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin. 
Sector
Pharmaceuticals
Calendar
06/16 | 10:00amPresentation
More about the company
Ratings of DBV Technologies
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about DBV TECHNOLOGIES
06/09European ADRs Slightly Higher Wednesday With Biotechs Leading While Miners Dr..
MT
06/02GLOBAL MARKETS LIVE : Tesla, AB Volvo, Credit Suisse, Amazon, Tyson Foods...
06/01DBV TECHNOLOGIES  : to Present at Upcoming Investor Conferences
PU
05/28European ADRs Move Higher in Friday Trading
MT
05/26European ADRs Trading Nearly Flat Wednesday; IDEX a Standout
MT
05/24DBV TECHNOLOGIES  : I.—CHARACTERISTIC FEATURES OF THE COMPANY (Form 8-K)
PU
05/24DBV TECHNOLOGIES S.A.  : Amendments to Articles of Inc. or Bylaws; Change in Fis..
AQ
05/21European ADRs Move Higher in Friday Trading
MT
05/20DBV TECHNOLOGIES S A  : AGM 2021 – Quorum
PU
05/19DBV TECHNOLOGIES S A  : Announces Results of its 2021 Ordinary and Extraordinary..
GL
05/19European ADRs Move Lower in Wednesday Trading
MT
05/17European ADRs Move Lower in Monday Trading
MT
05/07European ADRs Move Higher in Friday Trading
MT
05/05DBV TECHNOLOGIES S A  : Announces Filing of its First Form 10-Q for the First Qu..
GL
05/05DBV TECHNOLOGIES S A  : Management's Discussion and Analysis of Financial Condit..
AQ
More news
News in other languages on DBV TECHNOLOGIES
06/02STOCK MARKET PARIS : La fête n'est pas encore finie
06/02EN DIRECT DES MARCHES  : Alstom, Stellantis, Saint-Gobain, Cnova, Tesla, Credit ..
06/02DBV Technologies invitée à présenter lors des prochaines conférences investis..
05/28DBV TECHNOLOGIES  : plus forte baisse du SBF 120 à la mi-séance du vendredi 28 m..
05/20DBV TECHNOLOGIES S A  : AGM 2021 – Résultats du scrutin
More news
Analyst Recommendations on DBV TECHNOLOGIES
More recommendations
Chart DBV TECHNOLOGIES
Duration : Period :
DBV Technologies Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DBV TECHNOLOGIES
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Average target price 11,30 €
Last Close Price 10,25 €
Spread / Highest target 46,4%
Spread / Average Target 10,3%
Spread / Lowest Target -22,9%
EPS Revisions
Managers and Directors
NameTitle
Daniel Tassé Chief Executive Officer & Executive Director
Sébastien Robitaille Chief Financial Officer
Michel de Rosen Non-Executive Chairman
Pharis Mohideen Chief Medical Officer
Pascal Wotling Chief Technical Operations Officer
Sector and Competitors
1st jan.Capitalization (M$)
DBV TECHNOLOGIES136.28%680
MERCK KGAA10.55%81 596
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD51.17%38 130
KYOWA KIRIN CO., LTD.31.66%18 130
SK BIOPHARMACEUTICALS CO., LTD.-28.11%8 516
BETTA PHARMACEUTICALS CO., LTD.-0.39%6 906